| Identification | Back Directory | [Name]
Quinazoline, 4-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy]- | [CAS]
793722-88-0 | [Synonyms]
WAY-637081
2-(4-Chlorophenyl)-5-((quinazolin-4-yloxy)methyl)-1,3,4-oxadiazole
Quinazoline, 4-[[5-(4-chlorophenyl)-1,3,4-oxadiazol-2-yl]methoxy]- | [Molecular Formula]
C17H11ClN4O2 | [MOL File]
793722-88-0.mol | [Molecular Weight]
338.75 |
| Chemical Properties | Back Directory | [Boiling point ]
551.7±60.0 °C(Predicted) | [density ]
1.404±0.06 g/cm3(Predicted) | [form ]
Solid | [pka]
2.11±0.30(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
Casein kinase 1δ-IN-14 (compound 481) is a casein kinase inhibitor that can be used to study neurodegenerative diseases such as Alzheimer's disease[1]. | [References]
[1] Sheridan, et al. Casein kinase 1δ inhibitors for the treatment of neurodegenerative disorders. World Intellectual Property Organization, WO2012080729 A2. 2012-06-21. |
|
|